Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges [PDF]
Frontiers in MicrobiologyBurkholderia cepacia complex is a cause of serious lung infections in people with cystic fibrosis, exhibiting extremely high levels of antimicrobial resistance. These infections are difficult to treat and are associated with high morbidity and mortality.
Jack S. Canning +11 more
doaj +4 more sources
Spondylodiscitis caused by the Burkholderia cepacia complex [PDF]
Revista da Sociedade Brasileira de Medicina TropicalRulian Christi Souza Rodrigues Candido +4 more
doaj +4 more sources
A Rare Case of Burkholderia cepacia Complex Septic Arthritis [PDF]
Case Reports in Infectious Diseases, 2018 Bacteria of the Burkholderia cepacia complex have rarely been reported to cause septic arthritis. Cases have been reported in patients who were immunocompromised, at extremes of age or who had history of steroid injection or penetrating trauma. A 67-year-
John Koo, Gregory D. Deans
doaj +4 more sources
The multifarious, multireplicon Burkholderia cepacia complex
Nature Reviews Microbiology, 2005 The Burkholderia cepacia complex (Bcc) is a collection of genetically distinct but phenotypically similar bacteria that are divided into at least nine species. Bcc bacteria are found throughout the environment, where they can have both beneficial and detrimental effects on plants and some members can also degrade natural and man-made pollutants.
Eshwar, Mahenthiralingam +2 more
openaire +3 more sources
Burkholderia cepacia complex Cervical Osteomyelitis in an Intravenous Drug User
Case Reports in Infectious Diseases, 2018 Gram-negative vertebral osteomyelitis infections are increasing due to rising intravenous drug use but overall remain uncommon. Here, we present a case of Burkholderia cepacia complex cervical osteomyelitis in an intravenous drug user.
Sui Kwong Li, William B. Messer
doaj +2 more sources
DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III [PDF]
Journal of Clinical Microbiology, 2000 Bacteria of the Burkholderia cepacia complex consist of five discrete genomic species, including genomovars I and III and three new species: Burkholderia multivorans (formerly genomovar II), Burkholderia stabilis (formerly genomovar IV), andBurkholderia vietnamiensis (formerly genomovar V).
E, Mahenthiralingam +6 more
openaire +3 more sources
Burkholderia cepacia Complex Taxon K: Where to Split? [PDF]
Frontiers in Microbiology, 2020 The objective of the present study was to provide an updated classification for Burkholderia cepacia complex (Bcc) taxon K isolates. A representative set of 39 taxon K isolates were analyzed through multilocus sequence typing (MLST) and phylogenomic ...
Eliza Depoorter +10 more
doaj +4 more sources
Exploring phage–host interactions in Burkholderia cepacia complex bacterium to reveal host factors and phage resistance genes using CRISPRi functional genomics and transcriptomics [PDF]
Microbiology SpectrumComplex interactions of bacteriophages with their bacterial hosts determine phage host range and infectivity. While phage defense systems and host factors have been identified in model bacteria, they remain challenging to predict in non-model bacteria ...
Ben Diaz +3 more
doaj +2 more sources
Cepacia-Like Syndrome Caused by Burkholderia mutivorans [PDF]
Canadian Journal of Infectious Diseases, 2003 The variable severity of Burkholderia cepacia complex infections in cystic fibrosis (CF) has recently been ascribed to differences in the virulence between genomovars.
George Zahariadis +2 more
doaj +2 more sources
Environmental Burkholderia cepacia Complex Isolates from Human Infections
Emerging Infectious Diseases, 2007 Members of the Burkholderia cepacia complex (Bcc), found in many environments, are associated with clinical infections. Examining diverse species and strains from different environments with multilocus sequence typing, we identified >20% of 381 clinical ...
Adam Baldwin +13 more
doaj +2 more sources